NASDAQ:ORGO
Organogenesis Holdings Inc. Class A Stock News
$2.77
+0 (+0%)
At Close: May 21, 2024
Organogenesis Holdings Inc. (ORGO) Q1 2023 Earnings Call Transcript
11:50pm, Wednesday, 10'th May 2023
Organogenesis Holdings Inc. (NASDAQ:ORGO ) Q1 2023 Earnings Conference Call May 10, 2023 5:00 PM ET Company Participants Gary Gillheeney - President and CEO Dave Francisco - CFO Conference Call Partic
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2023 Financial Results on May 10, 2023
07:30am, Monday, 10'th Apr 2023
CANTON, Mass., April 10, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of
Why Shares of Unisys, Organogenesis, and Motorcar Parts of America Fell Today
06:29pm, Monday, 06'th Mar 2023
The S&P SmallCap 600 index dropped all three stocks.
Organogenesis Holdings Inc. (ORGO) Q4 2022 Earnings Call Transcript
10:17pm, Wednesday, 01'st Mar 2023
Organogenesis Holdings Inc. (NASDAQ:ORGO ) Q4 2022 Earnings Conference Call March 1, 2023 5:00 PM ET Company Participants Gary Gillheeney - President and Chief Executive Officer Dave Francisco - Chief
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 1, 2023
07:30am, Thursday, 09'th Feb 2023
CANTON, Mass., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of
Organogenesis Holdings Inc. (ORGO) Q3 2022 Earnings Call Transcript
09:24pm, Wednesday, 09'th Nov 2022
Organogenesis Holdings Inc. (NASDAQ:ORGO ) Q3 2022 Earnings Conference Call November 9, 2022 5:00 PM ET Corporate Participants Gary Gillheeney - President and Chief Executive Officer Dave Francisco -
Organogenesis: Finding A Spot For This Regenerative Medicines Company In My 'Bio Boom' Portfolio
04:53am, Tuesday, 18'th Oct 2022
The market-wide sell-off has uncovered countless investment opportunities in the small and mid-cap healthcare arena. I have rediscovered Organogenesis trading at an incredible discount. Organogenesis
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2022 Financial Results on November 9, 2022
09:12am, Monday, 26'th Sep 2022
CANTON, Mass., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of
Organogenesis Holdings Inc. to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
07:30am, Wednesday, 07'th Sep 2022
CANTON, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of
Why Organogenesis Stock Is Tumbling Today
03:40pm, Wednesday, 10'th Aug 2022
It didn't make as much money in the second quarter as investors were hoping.
Organogenesis Holdings Inc. (ORGO) CEO Gary Gillheeney on Q2 2022 Results - Earnings Call Transcript
06:50pm, Tuesday, 09'th Aug 2022
Organogenesis Holdings Inc. (NASDAQ:ORGO ) Q2 2022 Earnings Conference Call August 9, 2022 5:00 PM ET Company Participants Gary Gillheeney - President and Chief Executive Officer Dave Francisco - Chie
Organogenesis (ORGO) Stock Jumps 5.3%: Will It Continue to Soar?
09:14am, Wednesday, 13'th Jul 2022
Organogenesis (ORGO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increa
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2022 Financial Results on August 9, 2022
07:30am, Thursday, 30'th Jun 2022
CANTON, Mass., June 30, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of p
Organogenesis Holdings Inc. (ORGO) Q1 2022 Earnings Call Transcript
09:00am, Wednesday, 11'th May 2022 The Motley Fool
ORGO earnings call for the period ending March 31, 2022.
Organogenesis Holdings Inc. (ORGO) CEO Gary Gillheeney on Q1 2022 Results - Earnings Call Transcript
09:49pm, Tuesday, 10'th May 2022
Organogenesis Holdings Inc. (NASDAQ:ORGO ) Q1 2022 Earnings Conference Call May 10, 2022 5:00 PM ET Company Participants Gary Gillheeney - President and Chief Executive Officer David Francisco - Chief
